Alkosign reappoints five directors, schedules 6th AGM for September 29

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Alkosign Ltd board reappointed five directors for five-year terms
  • Remuneration fixes require shareholder approval at the upcoming AGM
  • Sixth annual general meeting scheduled for September 29, 2026
  • Director's Report for FY26 was approved during the September 4 meeting
powered bylight_fuzz_icon
50050308

*this image is generated using AI for illustrative purposes only.

Alkosign Ltd board of directors approved the reappointment of five directors for five-year terms and scheduled its sixth annual general meeting for September 29, 2026. The decision was taken during a board meeting held on September 4, 2026.

The company also approved the Director's Report for the financial year ended March 31, 2026. Shareholder approval is required for all director reappointments and remuneration fixes at the upcoming general meeting.

Director Reappointments

The board approved the following reappointments, effective from their respective dates:

  • Samir Narendra Shah: Reappointed as Chairman and Managing Director effective December 22, 2026.
  • Shrenik Kamlesh Shah: Reappointed as Whole-Time Director effective October 1, 2026.
  • Parshva Vinaykant Doshi: Reappointed as Non-Executive Independent Director effective December 22, 2026.
  • Seema Ashim Jhaveri: Reappointed as Non-Executive Independent Director effective December 22, 2026.
  • Yogesh Ramgopal Gupta: Reappointed as Non-Executive Independent Director effective December 22, 2026.

All appointments are subject to shareholder approval. The board also approved remuneration exceeding the overall managerial limit under Section 197 of the Companies Act, 2013.

AGM Details

The sixth annual general meeting is scheduled for Tuesday, September 29, 2026, at 12:00 noon. The event will be held at the company's registered office in Bhiwandi, Thane. M/s. Dilip Swarnkar & Associates has been appointed as the scrutinizer for the voting process.

The cut-off date for determining eligible voting members will be fixed as per regulatory guidelines.

Historical Stock Returns for Alkosign

1 Day5 Days1 Month6 Months1 Year5 Years
-0.49%-6.62%0.0%0.0%-23.15%0.0%

How might the approval of remuneration exceeding the Section 197 limit impact Alkosign's profitability and shareholder returns in the upcoming fiscal year?

What strategic initiatives or operational changes are expected under the continued leadership of the reappointed board members for the 2026-2027 term?

Are there any potential risks of shareholder dissent regarding the director reappointments or the proposed remuneration packages at the September AGM?

Alkosign Limited Schedules Board Meeting on May 29, 2026 to Approve FY26 Audited Financial Results

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Alkosign Limited has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve standalone and consolidated audited financial results for the financial year ended March 31, 2026. The intimation was filed on May 19, 2026, with the BSE SME Platform under Regulation 29 of SEBI (LODR) Regulations, 2015. The trading window for the company's equity shares has been closed since April 01, 2026, and will remain shut until 48 hours after the financial results are communicated to the stock exchange.

powered bylight_fuzz_icon
40733045

*this image is generated using AI for illustrative purposes only.

Alkosign Limited has notified the BSE SME Platform of an upcoming Board of Directors meeting, scheduled for Friday, May 29, 2026. The intimation was filed on May 19, 2026, by Managing Director Samir Narendra Shah, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to deliberate on key financial matters. The following agenda items have been disclosed:

Agenda Item: Details
Item 1: Consider and approve Standalone and Consolidated Audited Financial Results for the financial year ended March 31, 2026
Item 2: Any other agenda with the permission of the Chairman

Trading Window Closure

In continuation of the company's earlier intimation dated March 30, 2026, Alkosign has reiterated that the trading window for dealing in its equity shares has been closed effective April 01, 2026. This closure is in accordance with the company's Code of Conduct for Prevention of Insider Trading, framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed until 48 hours after the audited financial results for the financial year ended March 31, 2026, are communicated to the stock exchange.

Regulatory Compliance

The board meeting intimation has been submitted to the Department of Corporate Services at the BSE SME Platform, located at 25th Floor, P.J. Towers, Dalal Street, Fort, Mumbai - 400 001. The filing reflects the company's adherence to its obligations under the applicable provisions of the SEBI Listing Regulations.

Historical Stock Returns for Alkosign

1 Day5 Days1 Month6 Months1 Year5 Years
-0.49%-6.62%0.0%0.0%-23.15%0.0%

How might Alkosign's FY2026 audited financial results compare to its previous year's performance, and what revenue or profitability trends could emerge?

Will the board consider announcing any dividend, bonus shares, or capital restructuring alongside the financial results approval on May 29, 2026?

How could the trading window reopening after May 29 impact Alkosign's stock price and trading volumes on the BSE SME Platform?

More News on Alkosign

1 Year Returns:-23.15%